[ XXXX : clinical, laboratorial and histological study of 50 cases].

@entity1 @entity82 @entity1087 @entity1560 @entity39 @entity548 @entity75 @entity167 @entity281 @entity382 @entity99
The clinical, laboratorial and histological aspects of 50 cases of @entity99 were analysed, as well as the follow-up of 24 @entity1 . The mean age of the 50 @entity1 was 42,9 years (range: 25 to 65 years); 44 were males. The beginning of the symptomatology was insidious in great number of cases. The @entity382 was most habitual clinical signal (92% of cases). The @entity1087 was observed in 58% of the cases. Twenty six per cent of the @entity1 had not manifestation of advanced hepatopaty at the moment of diagnosis. The most constant laboratorial alteration (except the increase of gama-glutamil-transpeptidase, dosed in rare cases) was the increase of SGOT (94%). Histological examination showed @entity39 and inflammatory exudate in all cases; @entity1560 in 98%; Mallory bodies in 78%; @entity82 in 84%; @entity82 in 44%. In the group of @entity1 that came to the obit at the first internation, @entity1087 , digestive @entity548 , @entity75 , @entity281 , leucocitosis and decreased prothrombin activity. The follow-up of 24 cases (3 months to 5 years) showed aggravation of illness and frequent evolution to @entity82 in @entity1 that maintained the @entity167 ingestion.
